C57BL/6N-Slc13a5tm1a(EUCOMM)Hmgu/Ieg
Status | Available to order |
EMMA ID | EM:08618 |
International strain name | C57BL/6N-Slc13a5tm1a(EUCOMM)Hmgu/Ieg |
Alternative name | HEPD0667_2_B12 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc13a5tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Slc13a5 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Provider affiliation | Institute of Experimental Genetics, Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH) |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0667_2_B12. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Helmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany |
Animals used for archiving | heterozygous C57BL/6NTac |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Pyridoxine-dependent epilepsy / Orphanet_3006
- Undetermined early-onset epileptic encephalopathy / Orphanet_442835
- Amelocerebrohypohidrotic syndrome / Orphanet_1946
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- abnormal liver morphology / MGI
- abnormal hepatocyte morphology / MGI
- abnormal liver physiology / MGI
- decreased body length / MGI
- decreased body weight / MGI
- hyperactivity / MGI
- abnormal glucose homeostasis / MGI
- abnormal muscle physiology / MGI
- decreased circulating insulin level / MGI
- increased insulin sensitivity / MGI
- no phenotypic analysis / MGI
- decreased susceptibility to age related obesity / MGI
- abnormal glycerol level / MGI
- increased lean body mass / MGI
- increased energy expenditure / MGI
- abnormal metabolism / MGI
- increased oxygen consumption / MGI
- improved glucose tolerance / MGI
- decreased circulating glucose level / MGI
- decreased susceptibility to diet-induced obesity / MGI
- increased carbon dioxide production / MGI
- decreased liver triglyceride level / MGI
- decreased total body fat amount / MGI
- abnormal hepatocyte physiology / MGI
- abnormal susceptibility to weight gain / MGI
- decreased circulating lactate level / MGI
- increased muscle cell glucose uptake / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).